Exploitation of a novel phenothiazine derivative for its anti-cancer activities in malignant glioblastoma
The DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index.
Abstract
Glioblastoma remains the most malignant of all primary adult brain tumours with poor patient survival and limited treatment options. This study adopts a drug repurposing approach by investigating the anti-cancer activity of a derivative of the antipsychotic drug phenothiazine (DS00329) in malignant U251 and U87 glioblastoma cells. Results from MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and clonogenic assays showed that DS00329 inhibited short-term glioblastoma cell viability and long-term survival while sparing non-cancerous cells. Western blot analysis with an antibody to γH2AX showed that DS00329 induced DNA damage and flow cytometry and western blotting confirmed that it triggered a G1 cell cycle arrest which correlated with decreased levels in Cyclin A, Cyclin B, Cyclin D1 and cyclin dependent kinase 2 and an increase in levels of the cyclin dependent kinase inhibitor p21. DS00329 treated glioblastoma cells exhibited morphological and molecular markers typical of apoptotic cells such as membrane blebbing and cell shrinkage and an increase in levels of cleaved PARP. Flow cytometry with annexin V-FITC/propidium iodide staining confirmed that DS00329 induced apoptotic cell death in glioblastoma cells. We also show that DS00329 treatment of glioblastoma cells led to an increase in the autophagosome marker LC3-II and autophagy inhibition studies using bafilomycin A1 and wortmannin, showed that DS00329-induced-autophagy was a pro-death mechanism. Further…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“anti‐cancer agents that induce more than one form of programmed cell death are more efficacious and less prone to resistance [45]”
From Pyrvinium Pamoate Alone and With Gemcitabine Exhibits Anti‐Pancreatic Cancer Activity in 2D and 3D Cell Culture Models (2024) · cites this paper as [45]
In the citing paper
“the inactivation of the intrinsic apoptotic pathway is one of the mechanisms by which PDAC cells become resistant to GEM [45, 46]”
From Pyrvinium Pamoate Alone and With Gemcitabine Exhibits Anti‐Pancreatic Cancer Activity in 2D and 3D Cell Culture Models (2024) · cites this paper as [45]
Citations
Cites
1 retracted
MA, K., Zhang, C., Huang, M., Li, W., & Hu, G. (2016) · Oncology Reports · doi:10.3892/or.2016.4782 · Cited by 65
RetractedThe 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139
Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S., & Bonner, W. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5858 · Cited by 5,438
Erratum to: The 2007 WHO classification of tumours of the central nervous system
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-156115 · Cited by 4,442
Clonogenic assay of cells in vitro
Franken, N. A. P., Rodermond, H. M., Stap, J., Haveman, J., & van Bree, C. (2006) · Nature Protocols · doi:10.1038/nprot.2006.339 · Cited by 4,188
Wen, P. Y., & Kesari, S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0708126 · Cited by 3,511
Drug repositioning: identifying and developing new uses for existing drugs
Ashburn, T. T., & Thor, K. B. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1468 · Cited by 3,237
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio711 · Cited by 3,068
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
Apoptosis in cancer: from pathogenesis to treatment
Wong, R. S. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-87 · Cited by 2,836
Research works printed but not linked: 1
- Gupta R (1988) Bioactive molecules: phenothiazine and 1, 4-benzothiazines, Chemical and Biological Aspects, vol 4. Elsevier, Amsterdam
Cited by
Synthesis of Novel Chalcone-Based Phenothiazine Derivatives as Antioxidant and Anticancer Agents
Zahrani, N. A. A., El‐Shishtawy, R. M., Elaasser, M. M., & Asiri, A. M. (2020) · Molecules · doi:10.3390/molecules25194566 · Cited by 139
Autophagy Modulators in Cancer Therapy
Buzun, K., Gornowicz, A., Lesyk, R., Bielawski, K., & Bielawska, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115804 · Cited by 70
Poustforoosh, A., Faramarz, S., Nematollahi, M. H., Hashemipour, H., Tüzün, B., Pardakhty, A., & Mehrabani, M. (2021) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30178 · Cited by 57
Personalized Treatment of Glioblastoma: Current State and Future Perspective
Rončević, A., Koruga, N., Koruga, A. S., Rončević, R., Rotim, T., Šimundić, T., Kretić, D., Perić, M., Turk, T., & Štimac, D. (2023) · Biomedicines · doi:10.3390/biomedicines11061579 · Cited by 56
Phenothiazines as anti-cancer agents: SAR overview and synthetic strategies
Kumar, A., Vigato, C., Boschi, D., Lolli, M. L., & Kumar, D. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115337 · Cited by 47
Metadata
- Authors
- Omoruyi, S. I., Ekpo, O. E., Semenya, D. M., Jardine, A., & Prince, S.
- Affiliations
- University of Cape Town (ZA)
- University of the Western Cape (ZA)
- Corresponding author
- Prince, S.
- Venue
- Apoptosis
- Published
- 2020-02-08
- Volume
- 25
- Issue
- 3-4
- Pages
- 261-274
- ISSN
- 1360-8185 (ISSN-L)
- 1573-675X
- OpenAlex
- W3004606969
- Cited by
- 53
- References
- 81
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 9 · 2023: 6 · 2022: 10 · 2021: 6 · 2020: 4
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- APOPTOSIS (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Keywords
- glioblastoma, phenothiazines, drug repurposing, antipsychotic drugs, autophagy, G1 cell cycle arrest, DNA damage, PI3K/Akt signaling, p21, U251 cells, U87 cells, anticancer activity
- MeSH terms
- Antineoplastic Agents, Autophagy, Cell Cycle, Cell Survival, DNA Damage, Glioblastoma, Humans, Phenothiazines, Signal Transduction, Apoptosis, Phosphatidylinositol 3-Kinases, Cell Line, Tumor, Cell Proliferation, Proto-Oncogene Proteins c-akt, Drug Repositioning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exploitation of a novel phenothiazine derivative for its anti-cancer activities in malignant glioblastoma. https://app.cochat.ai/papers/10.1007/s10495-020-01594-5
- The paper
- Omoruyi, S. I., Ekpo, O. E., Semenya, D. M., Jardine, A., & Prince, S. (2020). Exploitation of a novel phenothiazine derivative for its anti-cancer activities in malignant glioblastoma. Apoptosis. https://doi.org/10.1007/s10495-020-01594-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.